GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

By sjmartinez • December 13, 2024

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib S, Venesy D, Shah S, Lenihan D, Vaduganathan M, Deswal A, Fonarow GC, Butler J, Nohria A, Kosiborod MN, Ganatra S. GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2024 Dec 10:S1071-9164(24)00962-X. doi: 10.1016/j.cardfail.2024.10.448. Epub ahead of print. PMID: 39667523.

Tags: Cardiology/Epi, GLP-1R agonists, Heart failure with preserved ejection fraction, Publications, SGLT 2 inhibitors

Related Posts

Trends and disparities in mortality associated with peripheral artery disease and hyperlipidemia, 1999-2024

Khan S, Hassan M, Hussain M, Dhedhi HAA, Fatima W, Nawaz J, Ahsan A, Pirih FNU, Khalid N, Qaisar M, Qureshi AA, Baig M, Eltawansy[...]

Adipose Tissue Releases Nucleosides

Zhang J, Le T, Ruiz-Torres V, Cohen M, Paharkova V, Abt E, Alnajjar HS, Tan J, Rashid K, Jones AE, Ball AB, Divakaruni AS, Paszkiewicz[...]

Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells

Li YR, Shen X, Zhu E, Li Z, Huang J, Le T, Tran C, Radu CG, Yang L. Targeting orthotopic and metastatic pancreatic cancer with[...]